DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Carboplatin (Carboplatin) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (62)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carboplatin disability. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 62   Next >>

Possible Carboplatin side effects in 65 year old female

Reported by a physician from Switzerland on 2012-08-22

Patient: 65 year old female

Reactions: Vomiting, Diarrhoea, Anaemia, General Physical Health Deterioration

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Avastin
    Indication: Adenocarcinoma
    Start date: 2011-12-30

Cisplatin
    Indication: Adenocarcinoma
    Start date: 2011-12-30

Carboplatin
    Indication: Adenocarcinoma
    Start date: 2011-02-14

Pemetrexed Disodium
    Indication: Adenocarcinoma
    Start date: 2011-12-30

Other drugs received by patient: Crestor; Potassium Chloride; Norfloxacin; Dolpasse



Possible Carboplatin side effects in 65 year old female

Reported by a physician from Switzerland on 2012-08-21

Patient: 65 year old female

Reactions: Vomiting, Diarrhoea, Anaemia, General Physical Health Deterioration, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Pemetrexed Disodium
    Dosage: date of last dose prior to sae: 20/jan/2012
    Indication: Adenocarcinoma
    Start date: 2011-12-30

Cisplatin
    Dosage: date of last dose prior to sae: 20/jan/2012
    Indication: Adenocarcinoma
    Start date: 2011-12-30

Avastin
    Dosage: date of last dose prior to sae: 20/jan/2012
    Indication: Adenocarcinoma
    Start date: 2011-12-30

Carboplatin
    Indication: Adenocarcinoma
    Start date: 2011-02-14

Other drugs received by patient: Crestor; Dolpasse; Potassium Chloride; Norfloxacin



Possible Carboplatin side effects in male

Reported by a physician from Japan on 2012-07-27

Patient: male, weighing 48.0 kg (105.6 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia Aspiration, Vomiting, Pulmonary Embolism, Leukoencephalopathy, Pyrexia, Neutrophil Count Decreased, Decreased Appetite

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Alimta
    Indication: Lung Adenocarcinoma Recurrent
    Start date: 2012-03-13
    End date: 2012-03-13

Methylprednisolone Sodium Succinate
    Dosage: dosage is uncertain.
    Indication: Leukoencephalopathy
    Start date: 2012-04-26
    End date: 2012-01-01

Avastin
    Indication: Lung Neoplasm Malignant
    Start date: 2012-03-13
    End date: 2012-03-13

Carboplatin
    Dosage: dosage: 5 auc a day
    Indication: Lung Adenocarcinoma Recurrent
    Start date: 2012-03-13
    End date: 2012-03-13

Other drugs received by patient: Tannalbin; Panvitan; Flivas; Neuer; Medicon; Urso 250; Eviprostat



Possible Carboplatin side effects in male

Reported by a pharmacist from United States on 2012-07-25

Patient: male, weighing 106.3 kg (233.9 pounds)

Reactions: Chest Pain

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Carboplatin
    Dosage: 180-150mg 4 cycles iv drip
    Indication: Head and Neck Cancer
    Start date: 2012-03-19
    End date: 2012-04-09

Dexamethasone Sodium Phosphate
    Dosage: 20mg once w/ chemo iv drip
    Indication: Vomiting
    Start date: 2012-03-19
    End date: 2012-04-25

Other drugs received by patient: Metorpolol Tartrate 300mg; Diphenhydramine 50mg; Rosuvastatin; Isosorbide Dinitrate 90mg; Ondansetron 8MG IV; Cetuximab 580mg; Ranitidine 450mg; Acetaminophen; Lisinopril; Amlodipine Besylate; Levothyroxine NA 0.088mg



Possible Carboplatin side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: 58 year old male, weighing 58.0 kg (127.6 pounds)

Reactions: Febrile Neutropenia, Radiation Mucositis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Carboplatin
    Dosage: 1df auc =5, dose redused to auc 3.
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Gemcitabine Hydrochloride
    Dosage: last dose on:11jun12 dose redused to:500mg/m2
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Ramucirumab
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Other drugs received by patient: Warfarin Sodium; Levaquin; Roxanol; Neupogen; Zometa; Methadone HCL; Promethazine; Prilosec; Platelets; Ondansetron



Possible Carboplatin side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-17

Patient: 58 year old male, weighing 58.0 kg (127.6 pounds)

Reactions: Oropharyngeal Pain, Neutropenia, Radiation Mucositis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Ramucirumab
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Gemcitabine Hydrochloride
    Dosage: last dose on:11jun12 dose redused to:500mg/m2
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Carboplatin
    Dosage: 1df auc =5, dose redused to auc 3.
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Other drugs received by patient: Prilosec; Ondansetron; Neupogen; Methadone HCL; Levaquin; Roxanol; Zometa; Promethazine; Warfarin Sodium; Platelets



Possible Carboplatin side effects in male

Reported by a physician from United States on 2012-07-17

Patient: male, weighing 64.7 kg (142.3 pounds)

Reactions: Febrile Neutropenia, Radiation Mucositis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Gemcitabine Hydrochloride
    Dosage: 500 mg/m2, other

Gemcitabine Hydrochloride
    Dosage: 1000 mg/m2, other
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04
    End date: 2012-06-11

Ramucirumab (1121b) (Ly3009806)
    Dosage: 10 mg/kg, other
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Carboplatin
    Dosage: unk, other
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04
    End date: 2012-06-04

Carboplatin
    Dosage: 3 df, other

Other drugs received by patient: Hydrocodone; Roxanol; Ondansetron; Promethazine; Zometa; Levaquin; Methadon HCL TAB; Prilosec; Warfarin Sodium; Neupogen; Platelets; Promethazine



Possible Carboplatin side effects in 4 month old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-10

Patient: 4 month old female

Reactions: Wrong Technique in Drug Usage Process, Deafness Bilateral, Incorrect Drug Administration Duration, Drug Level Increased, Drug Dispensing Error

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Carboplatin



Possible Carboplatin side effects in male

Reported by a physician from United States on 2012-07-05

Patient: male, weighing 64.7 kg (142.3 pounds)

Reactions: Radiation Mucositis, Neutropenia, Oropharyngeal Pain

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Carboplatin
    Dosage: unk, other
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04
    End date: 2012-06-04

Gemcitabine Hydrochloride
    Dosage: 500 mg/m2, other

Ramucirumab (1121b) (Ly3009806)
    Dosage: 10 mg/kg, other
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Gemcitabine Hydrochloride
    Dosage: 1000 mg/m2, other
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04
    End date: 2012-06-11

Carboplatin
    Dosage: 3 df, other

Other drugs received by patient: Ondansetron; Levaquin; Prilosec; Roxanol; Promethazine; Zometa; Hydrocodone Bitartrate; Warfarin Sodium; Methadon HCL TAB; Platelets; Neupogen; Promethazine



Possible Carboplatin side effects in male

Reported by a physician from Japan on 2012-06-29

Patient: male, weighing 48.0 kg (105.6 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia Aspiration, Vomiting, Pulmonary Embolism, Pyrexia, Leukoencephalopathy, Neutrophil Count Decreased, Decreased Appetite

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Alimta
    Indication: Lung Adenocarcinoma Recurrent
    Start date: 2012-03-13
    End date: 2012-03-13

Avastin
    Indication: Lung Neoplasm Malignant
    Start date: 2012-03-13
    End date: 2012-03-13

Carboplatin
    Dosage: dosage: 5 auc a day
    Indication: Lung Adenocarcinoma Recurrent
    Start date: 2012-03-13
    End date: 2012-03-13

Other drugs received by patient: Eviprostat; Flivastatin Sodium; Tannalbin; Neuer; Medicon; Panvitan; Excelase (Unk Ingredients); Urso 250



Possible Carboplatin side effects in female

Reported by a physician from Germany on 2012-06-13

Patient: female, weighing 95.0 kg (209.0 pounds)

Reactions: Pulmonary Embolism

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Bevacizumab
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-06-01

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-02-28

Carboplatin
    Indication: Breast Cancer
    Start date: 2012-02-28

Taxol
    Indication: Breast Cancer
    Start date: 2012-02-28



Possible Carboplatin side effects in 52 year old male

Reported by a physician from Austria on 2012-06-04

Patient: 52 year old male, weighing 108.0 kg (237.6 pounds)

Reactions: Dyspnoea, Cardiac Failure, Neoplasm Malignant, Radiation Pneumonitis, Cardiomyopathy

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Carboplatin
    Indication: Chemotherapy
    Start date: 2011-03-24
    End date: 2011-07-13

Avastin
    Indication: Chemotherapy
    Start date: 2011-03-24
    End date: 2011-09-21

Alimta
    Indication: Chemotherapy
    Start date: 2011-03-24
    End date: 2011-07-13



Possible Carboplatin side effects in 52 year old male

Reported by a individual with unspecified qualification from Denmark on 2012-06-01

Patient: 52 year old male

Reactions: Dyspnoea, Neoplasm Progression, Radiation Pneumonitis, Metastatic Bronchial Carcinoma, Cardiomyopathy, Cardiac Failure Congestive

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Carboplatin
    Dosage: iv
    Indication: Chemotherapy
    Start date: 2011-03-24
    End date: 2011-07-13

Alimta
    Dosage: 500 mg/m**2
    Indication: Chemotherapy
    Start date: 2011-03-24
    End date: 2011-07-13

Avastin
    Dosage: 7.5 mg/kg
    Indication: Chemotherapy
    Start date: 2011-03-24
    End date: 2011-09-21



Possible Carboplatin side effects in female

Reported by a physician from France on 2012-05-31

Patient: female

Reactions: Visual Acuity Reduced Transiently

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 30 milligram/sq. meter
    Indication: Ovarian Cancer
    Start date: 2011-10-19

Carboplatin
    Dosage: 475 milligram
    Indication: Ovarian Cancer
    Start date: 2011-10-19

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Ovarian Cancer
    Start date: 2011-10-20
    End date: 2011-11-03

Other drugs received by patient: Lamotrigine; Lovenox; Oxazepam



Possible Carboplatin side effects in female

Reported by a physician from United States on 2012-05-24

Patient: female

Reactions: Metastases To Thorax, Metastases To Peritoneum

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Ovarian Cancer Recurrent
    Start date: 2000-01-01
    End date: 2009-01-01

Carboplatin
    Indication: Ovarian Cancer Recurrent



Possible Carboplatin side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-23

Patient: 68 year old female, weighing 63.0 kg (138.6 pounds)

Reactions: Diplopia, Iiird Nerve Paralysis, Metastases To Meninges, Iiird Nerve Disorder

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Carboplatin
    Indication: Lung Cancer Metastatic

Navelbine
    Dosage: 25 mg/m2 iv
    Indication: Lung Cancer Metastatic
    Start date: 2012-03-19
    End date: 2012-04-02



Possible Carboplatin side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from Austria on 2012-05-22

Patient: 52 year old male, weighing 108.0 kg (237.6 pounds)

Reactions: Dyspnoea, Cardiac Failure, Neoplasm Progression, Radiation Pneumonitis, Cardiomyopathy, Left Ventricular Failure

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Carboplatin
    Dosage: unk
    Indication: Chemotherapy
    Start date: 2011-03-24
    End date: 2011-06-01

Alimta
    Dosage: 500 mg/m2, unk
    Indication: Chemotherapy
    Start date: 2011-03-24
    End date: 2011-07-13

Alimta
    Dosage: unk
    Start date: 2012-04-30

Avastin
    Dosage: 7.5 mg/kg, unk
    Indication: Chemotherapy
    Start date: 2011-03-24
    End date: 2011-07-13

Avastin
    End date: 2011-09-21

Carboplatin
    Dosage: unk
    Indication: Chemotherapy
    Start date: 2011-06-01
    End date: 2011-07-13



Possible Carboplatin side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-17

Patient: 48 year old female, weighing 77.0 kg (169.4 pounds)

Reactions: Optic Atrophy, Retinal Haemorrhage, Visual Impairment, Visual Acuity Reduced, Vision Blurred, Papilloedema

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Carboplatin

Other drugs received by patient: Dexamethasone; Omeprazole; Paclitaxel; Acetaminophen; Codeine Phosphate (Codeine Phosphate); Ranitidine Hydrochloride; Ferrous Sulfate TAB; Ondansetron; Domperidone (Domperidone)



Possible Carboplatin side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-15

Patient: 50 year old female

Reactions: Telangiectasia, Oedema Peripheral, Finger Amputation, Gangrene, Peripheral Ischaemia, RED Blood Cell Sedimentation Rate Increased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gemcitabine
    Dosage: ; iv
    Indication: Neoplasm Malignant

Carboplatin
    Dosage: ; iv
    Indication: Neoplasm Malignant

Other drugs received by patient: Grape Seed; Thyroid TAB; Multi-Vitamin



Possible Carboplatin side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-14

Patient: 48 year old female, weighing 34.9 kg (76.8 pounds)

Reactions: Optic Atrophy, Retinal Haemorrhage, Drug Hypersensitivity, Visual Acuity Reduced, Vision Blurred, Papilloedema

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Carboplatin

Other drugs received by patient: Ferrous Sulfate TAB; (Domperidone); Omeprazole; Ondansetron; Dexamethasone; Ranitidine; Acetaminophen; (Codeine Phosphate); Paclitaxel



Possible Carboplatin side effects in 48 year old female

Reported by a physician from United Kingdom on 2012-05-13

Patient: 48 year old female, weighing 77.0 kg (169.4 pounds)

Reactions: Optic Atrophy, Retinal Haemorrhage, Visual Impairment, Visual Acuity Reduced, Vision Blurred, Papilloedema

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Carboplatin

Other drugs received by patient: Domperidone; Dexamethasone; Codeine Phosphate; Omeprazole; Paclitaxel; Acetaminophen; Ondansetron; Ranitidine; Ferrous Sulfate TAB



Possible Carboplatin side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-08

Patient: 48 year old female, weighing 77.0 kg (169.4 pounds)

Reactions: Optic Atrophy, Retinal Haemorrhage, Visual Impairment, Visual Acuity Reduced, Vision Blurred, Optic Neuritis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Carboplatin

Other drugs received by patient: Dexamethasone; Ranitidine; Omeprazole; Acetaminophen; Domperidone; Ferrous Sulfate TAB; Codeine Phosphate; Ondansetron; Paclitaxel



Possible Carboplatin side effects in male

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-04-26

Patient: male

Reactions: Dysarthria, Visual Impairment, Hypothyroidism, Ataxia, Deafness, Coordination Abnormal, Cognitive Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Temozolomide
    Dosage: not reported

(Therapeutic Radiopharmaceuticals)
    Dosage: 35 gy, unknown, other

Vincristine Sulfate
    Dosage: not reported

Etoposide
    Dosage: not reported

Cyclophosphamide
    Dosage: not reported

Carboplatin
    Dosage: 700 mg/m 2 milligram(s)/sq. meter

Cisplatin
    Dosage: 80 mg/m 2 milligram(s)/sq. meter

Depocyt
    Dosage: 50 mg milligram(s), intrathecal

(Lomustine)
    Dosage: not reported



Possible Carboplatin side effects in 60 year old male

Reported by a physician from Switzerland on 2012-04-24

Patient: 60 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Osteonecrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2011-11-01

Zometa
    Indication: Bone Neoplasm
    Start date: 2009-06-16
    End date: 2012-02-09

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-09
    End date: 2010-03-09

Carboplatin
    Indication: Breast Cancer
    Start date: 2011-11-01

Taxotere
    Indication: Breast Cancer
    Start date: 2011-11-01

Taxol
    Indication: Breast Cancer
    Start date: 2010-03-09
    End date: 2011-02-14

Other drugs received by patient: Neulasta



Possible Carboplatin side effects in 60 year old male

Reported by a consumer/non-health professional from Switzerland on 2012-04-24

Patient: 60 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Osteonecrosis, Aneurysm

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Zometa
    Dosage: intrp and reintiated,last dose on 09feb12 again suspended
    Indication: Neoplasm Malignant
    Start date: 2009-06-16
    End date: 2012-02-09

Herceptin
    Indication: Breast Cancer
    Start date: 2011-11-01

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-09
    End date: 2011-02-14

Carboplatin
    Indication: Breast Cancer
    Start date: 2011-11-01

Taxotere
    Indication: Breast Cancer
    Start date: 2011-11-01

Taxol
    Indication: Breast Cancer
    Start date: 2010-03-09
    End date: 2011-02-14

Other drugs received by patient: Neulasta



Possible Carboplatin side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-04-20

Patient: 60 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Osteonecrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Carboplatin
    Start date: 2011-11-01

Taxol
    Start date: 2010-03-09
    End date: 2011-02-14

Zometa
    Indication: Bone Neoplasm Malignant
    Start date: 2009-06-16
    End date: 2011-01-01

Taxotere
    Start date: 2011-11-01

Zometa
    Start date: 2011-01-01
    End date: 2012-02-09

Avastin
    Dosage: frequency reported as one per 2 week
    Start date: 2010-03-09
    End date: 2011-02-14

Trastuzumab
    Start date: 2011-11-01

Other drugs received by patient: Neulasta



Possible Carboplatin side effects in 65 year old female

Reported by a physician from Switzerland on 2012-04-11

Patient: 65 year old female

Reactions: Vomiting, Diarrhoea, Anaemia, General Physical Health Deterioration

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cisplatin
    Indication: Adenocarcinoma
    Start date: 2011-12-30

Avastin
    Indication: Adenocarcinoma
    Start date: 2011-12-30

Carboplatin
    Indication: Adenocarcinoma
    Start date: 2011-02-14

Pemetrexed Disodium
    Indication: Adenocarcinoma
    Start date: 2011-12-30

Other drugs received by patient: Crestor; Dolpasse; Norfloxacin; Potassium Chloride



Possible Carboplatin side effects in female

Reported by a physician from France on 2012-04-05

Patient: female

Reactions: Blindness Unilateral

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Ovarian Cancer
    Start date: 2011-10-20
    End date: 2011-11-03

Doxorubicin Hydrochloride
    Dosage: 30 milligram/sq. meter
    Indication: Ovarian Cancer
    Start date: 2011-10-19

Carboplatin
    Dosage: 475 milligram
    Indication: Ovarian Cancer
    Start date: 2011-10-19

Other drugs received by patient: Lovenox; Lamotrgine; Oxazepam



Possible Carboplatin side effects in 3 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-05

Patient: 3 year old

Reactions: Respiratory Failure, Drug Interaction

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Carboplatin

Other drugs received by patient possibly interacting with the suspect drug:
Etoposide
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Cyclophosphamide
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Thiotepa
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma



Possible Carboplatin side effects in 3 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-29

Patient: 3 year old

Reactions: Respiratory Failure, Pneumomediastinum, Acute Respiratory Distress Syndrome, Pneumothorax

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Etoposide
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Thiotepa
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Cyclophosphamide
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Carboplatin
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017